Another province announced the list of key monitoring drugs, and the outflow of prescriptions will be regulated!

Since the establishment of the medical insurance bureau, the key monitoring drugs have attracted the attention of the industry Recently, another province has focused on monitoring the outflow of the list of rational drugs Recently, the first batch of key monitoring drugs in Zhejiang province came out, and the industry came out with the first batch of list of key monitoring drugs for rational use issued by the health and Health Commission of Zhejiang Province, involving 32 varieties Among them, on the basis of the national key monitoring drugs, 12 generic drugs have been added in the province, including Xueshuantong for injection, thymosin for injection, Kangai injection, xiaochanping injection (intravenous injection), Shenqifuzheng injection, citicoline sodium capsule, Aidi injection, salvianolic acid salt for injection, elemene injection, etc According to the circulation notice, the first batch of list of key monitoring drugs in Zhejiang Province will be fully implemented after October 30 At the same time, Zhejiang made it clear that medical institutions should not delete the drugs included in the "provincial directory" when formulating the directory of their own institutions If the drugs are not included in the drug directory of their own institutions or are not used in the diagnosis and treatment scope of their own institutions, they should be expressed in the way of notes; in other words, the provincial monitoring directory should not be deleted, and there is no room for conversion In addition, Zhejiang will carry out dynamic supervision on key monitoring drugs Once unreasonable drugs are found, they will be included in the key monitoring directory, without a buffer period In order to fully monitor and eliminate the hidden benefits outside the hospital, Zhejiang also proposes that the prescription outside the hospital should be included in the platform circulation and supervision scope, and the outflow of prescription for the first province in China will also be supervised Since July this year, the national health and Health Commission issued the first batch of national key monitoring and rational drug use directories, many provinces and cities have implemented the requirements of the national health and Health Commission and formulated and published key monitoring directories According to incomplete statistics, at present, 12 provinces have published the catalogue of drugs for key monitoring and rational use of drugs, namely, Zhejiang, Jiangxi, Heilongjiang, Guangdong, Jiangsu, Hebei, Shaanxi, Shanxi, Guizhou, Hainan, Inner Mongolia, Tibet and Xinjiang; in addition, there are 7 cities and 4 hospitals that have opened the catalogue of drugs for public monitoring, involving more than 170 varieties According to the published catalogue of key monitoring and rational use of drugs, the monitoring catalogue of each province has been adjusted and moved on the basis of the catalogue published by the state, most of which are added on the basis of the state, for example, this time Zhejiang Province added "12 generic drugs"; previously, on September 29, Shanxi Province added proton pump inhibitors (including omeprazole, pantoprazole, Lansoprazole On September 23, Guangdong Dongguan also added six key monitoring drugs, namely, deer and melon polypeptide, alanyl glutamine, bone and melon extract, pidomode, xingxiong and spleen Aminopeptide This time, Zhejiang clearly proposed that when irrational drugs were used or there were too many prescriptions and orders in the daily outpatient and emergency prescriptions and ward (District) orders, the drugs should be included in the list of drugs for key monitoring of rational drugs in this institution in time It can be seen that on this basis, Zhejiang will focus on monitoring drugs or further increase In addition, most provinces' key monitoring drugs are supplemented on the basis of the state It can be seen that the state and provinces control the auxiliary drugs strictly In order to effectively curb the abuse of auxiliary drugs, more auxiliary drugs are included in the scope of key monitoring or become a trend At the same time, drug sales will be affected In order to maintain drug sales, how can drugs help themselves? Price reduction? rub one's eyes and wait Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.